Table 1 Neurotoxicities: distribution of neurological signs within the five categories.
From: Description of neurotoxicity in a series of patients treated with CAR T-cell therapy
Neurological signs | n | Categories | n |
|---|---|---|---|
Aphasia | 10 | Cognitive signs | 43 |
Executive syndrome | 7 | ||
Agraphia | 5 | ||
Cognitive slowness | 5 | ||
Confusional state | 4 | ||
Apraxia | 2 | ||
Disorientation | 2 | ||
Restlessness | 2 | ||
Attentional disorders | 1 | ||
Dysarthria | 1 | ||
Dyscalculia | 1 | ||
Hallucination | 1 | ||
Memory disorders | 1 | ||
Neglect syndrome | 1 | ||
Cerebellar syndrome | 7 | Non-pyramidal motor disorders | 16 |
Myoclonus | 4 | ||
Tremor | 3 | ||
Asterixis | 1 | ||
Dyskinesia | 1 | ||
Consciousness disorders | 6 | Consciousness disorders | 5 |
Seizures | 3 | Seizures | 3 |
Headaches | 5 | Miscellaneous | 9 |
Dysesthesias | 2 | ||
Meningismus | 1 | ||
Transitory focal weakness | 1 |
